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Background: Hyponatremia (HN) is a well known marker for mortality among patients with systolic heart failure (HF); however, the mode of death 
whether related to ventricular arrhythmias (VA) or HF progression remains unknown.
Methods: We identified 911 patients with an EF≤40% and baseline sodium (Na) values who underwent ICD implantation. HN was defined as Na ≤ 
136mg/dl (N=401, 44%). Patients were grouped according to mild HN (134-136, N=267), moderate HN (131-133, N=104) and severe HN (≤130, 
N=30). Multivariable Cox proportional analysis was used to calculate the adjusted hazard ratios (AHR) among each HN group, as compared to 
patients with a normal Na (≥137, N=510, 56%), on the incidence of all-cause mortality, appropriate ICD therapy for VA and HF hospitalization.
Results: Overall the mean age was 67 ± 12 years, EF of 24 ± 18%, 78% male, with 61% implanted for primary prevention indications. When 
compared to patients with normal Na, those with moderate (mean Na 132 ± 0.7) and severe HN (mean Na 128 ± 2) exhibited a 2 and 3 fold 
increased risk in mortality with a similar increase in probability of HF hospitalization [AHR 1.9 (95% CI 1.1- 3.1) p=.02] and [AHR 3.0 (95% CI 1.4 - 
6.3) p=.004, figure A] but did not differ in the risk of appropriate ICD therapy [AHR 0.8 (95% CI 0.6 - 1.8) p=0.26] and [AHR 0.7 (95% CI 0.5 - 1.4) 
p=0.32, figure B]
Conclusions: Heart failure patients with hyponatremia and ICD are at an increased risk of death that is mediated by progressive pump dysfunction 
and not related to sudden cardiac death. 
